Immunic investors
Witryna26 mar 2024 · Immunic (IMUX) Investor Presentation - Slideshow Oct 31. Immunic, Inc. Announces Results From Interim Safety Analysis and Recruitment Update From its Ongoing Phase 2 CALVID-1 Trial of IMU-838 in Patients With Moderate COVID-19 Sep 30. Immunic, Inc. has completed a Follow-on Equity Offering in the amount of $90 … WitrynaProvides key financial indicators of Immunic (IMUX), including historical and latest data and analysis. You can query by quarterly, mid-term, and annual reports, and compare historical data easily.
Immunic investors
Did you know?
Witryna23 lut 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information … WitrynaImmunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune …
Witryna11 kwi 2024 · The trading price of Immunic Inc. (NASDAQ:IMUX) closed lower on Monday, April 10, closing at $1.33, -4.32% lower than its previous close. In examining the 52-week price action we see that the stock hit a 52-week high of $12.22 and a 52-week low of $1.11. ... Investors’ optimism about the company’s current quarter earnings … Witryna11 kwi 2024 · The trading price of Immunic Inc. (NASDAQ:IMUX) closed lower on Monday, April 10, closing at $1.33, -4.32% lower than its previous close. In examining …
Witryna6 kwi 2024 · Immunic to Participate in Investor and Scientific Conferences in November and December. NEW YORK , Nov. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chron... Witryna5 kwi 2024 · Immunic Therapeutics Adds New Investors and Completes Series A Financing Round of Total EUR 31.7 Million Read More . Posted by Jessica. February …
Witryna23 lut 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx …
Witryna10 maj 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … can d mannose be taken with antibioticsWitryna12 kwi 2024 · 所属药企Immunic AG直接表示，除非有人愿意合作开发，不然这个适应症就永远不做了。 结果过了10个月，维持治疗组的试验出炉，它又站起来了。 CEO当 … c and m body shop mount olive msWitryna23 lut 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx Communications Group Paula Schwartz +1 917 633 7790 c and m appliancesWitryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Rx Communications Group … c and m brighton llpWitrynaDec-10-21 06:26AM. Insiders who bought Immunic, Inc. (NASDAQ:IMUX) stock in the last 12 months recover some losses, but still down US$82k. Simply Wall St. Dec-09-21 04:01PM. Immunic, Inc. Announces Enrollment of the First Patient in its Phase 1 Trial of IMU-935 in Metastatic Castration-Resistant Prostate Cancer. candmclubc and m build groupWitryna10 paź 2024 · NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ("Immunic" or the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, today announced it has entered into a … fish shell change theme